Our counselors and office staff assist you by phone ( 305)490-2240 during standard business hours (10:00 am to 6:00 pm Eastern Time) throughout your 4-phase program with us
A history of severe allergic reactions to Semaglutide
Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date always verify current benefits directly with Aetna before making any decision
Semaglutide data were derived from the SUSTAIN (111, FORTE) and STEP (2, UP-DM) programs, whereas tirzepatide data were obtained from SURPASS (16) and SURMOUNT-2 trials
Our findings indicate that oral semaglutide could be a promising option in need of treatment for diabetes and cardiovascular risk. Looking ahead, the researchers will look to implement findings in a real-world setting to better inform clinical next steps